The great escape: Is immune evasion required for tumor progression?
- 1 August 1999
- journal article
- editorial
- Published by Springer Nature in Nature Medicine
- Vol. 5 (8) , 874-875
- https://doi.org/10.1038/11311
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- Inhibition of cell growth and induction of apoptotic cell death by the human tumor-associated antigen RCAS1Nature Medicine, 1999
- Genomic amplification of a decoy receptor for Fas ligand in lung and colon cancerNature, 1998
- Tumor expression of Fas ligand (CD95L) and the consequencesCurrent Opinion in Immunology, 1998
- HER-2/neu Oncogenic Protein: Issues in Vaccine DevelopmentCritical Reviews in Immunology, 1998
- CD28/B7 Costimulation: A ReviewCritical Reviews in Immunology, 1998
- T cell defined tumor antigensCurrent Opinion in Immunology, 1997
- Antitumor effect of locally produced CD95 ligandNature Medicine, 1997
- Breast cancer–associated antigen, DF3/MUC1, induces apoptosis of activated human T cellsNature Medicine, 1996
- Mechanisms That Contribute to the Development of Lymphoid Malignancies: Roles for Genetic Alterations and Cytokine ProductionCritical Reviews in Immunology, 1996